scispace - formally typeset
J

Juliana Mozer Sciani

Researcher at Instituto Butantan

Publications -  66
Citations -  923

Juliana Mozer Sciani is an academic researcher from Instituto Butantan. The author has contributed to research in topics: Venom & Medicine. The author has an hindex of 16, co-authored 53 publications receiving 739 citations. Previous affiliations of Juliana Mozer Sciani include University of São Paulo & Universidade São Francisco.

Papers
More filters
Journal ArticleDOI

Africanized honey bee (Apis mellifera) venom profiling: Seasonal variation of melittin and phospholipase A(2) levels.

TL;DR: It was possible to perceive a seasonal variation on the venom contents of melittin and phospholipase A(2), but both compounds presented a synchronized variation of their levels, with an increased production in the same months.
Journal ArticleDOI

Differences and Similarities among Parotoid Macrogland Secretions in South American Toads: A Preliminary Biochemical Delineation

TL;DR: A biochemical characterization of the components of the poison of eight Rhinella species and one Rhaebo by means of RP-HPLC with either UV or MS detection and by SDS-PAGE is performed to verify whether phylogenetic and biological differences, such as habitat, diet, and defensive strategies, between them may also be reflected in poison composition.
Journal ArticleDOI

Skin glands, poison and mimicry in dendrobatid and leptodactylid amphibians

TL;DR: The data suggest that both Ameerega picta and L. lineatus are toxic or unpalatable and transmit common warning signals to predators, which represents a case of Müllerian mimicry.
Journal ArticleDOI

Isolation and characterization of a novel bradykinin potentiating peptide (BPP) from the skin secretion of Phyllomedusa hypochondrialis

TL;DR: This study describes the isolation and biological characterization of a novel BPP isolated from the skin secretion of the Brazilian tree-frog Phyllomedusa hypochondrialis, named Phypo Xa, able to potentiate bradykinin activities in vivo and in vitro, as well as efficiently and competitively inhibit ACE.